ESPN all but confirms initial report of Tarik Skubal’s timeline had everything to do with Scott Boras

The Detroit Tigers never promised Tarik Skubal would be back in a month. Scott Boras did.

And thanks to ESPN’s latest reporting, it’s becoming increasingly obvious that the ultra-optimistic timeline surrounding Skubal’s elbow surgery was driven less by the Tigers and more by the people who have the most to gain financially from calming the market.

From the moment Detroit announced Skubal would undergo surgery to remove a loose body from his left elbow, the organization stayed measured. Cautious, even. The Tigers repeatedly emphasized that they wouldn’t know a realistic recovery timeline until after the procedure was over. There were no guarantees, no promises, no “he’ll be back in a few weeks.”

Then came Jon Heyman.

First, Heyman reported Skubal’s scratch from his scheduled start was merely precautionary and that the “hope and belief” was he’d be fine. Thirty minutes later, The Athletic's Cody Stavenhagen revealed the reality: Skubal was heading for surgery. That alone was enough to make Tigers fans skeptical of whatever came next.

Sure enough, once the surgery was completed, Heyman returned with another aggressively optimistic update: the procedure was such a success that even a two-month recovery was considered “conservative,” with a possible return in four-to-six weeks.

Now ESPN’s Buster Olney has essentially confirmed where that optimism originated. Scott Boras himself went on “Baseball Tonight” and openly campaigned for the idea that this wasn’t a typical loose-body removal procedure at all. Boras described Dr. Neal ElAttrache’s use of a NanoScope as “almost like receiving a shot,” even jokingly branding it “a Skubal scope.”

That's more marketing than it is medical analysis, and it makes complete sense why Boras would be the one pushing this narrative.

Scott Boras' optimistic Tarik Skubal timeline is about leverage management, and Tigers fans are right to be skeptical

Skubal is headed toward free agency this winter as a two-time Cy Young winner entering his prime. The second the words “elbow surgery” appeared in headlines, executives, fans and rival agents immediately started recalculating his value. If teams begin believing this could linger into the second half — or worse, impact his long-term durability — it changes conversations worth hundreds of millions of dollars.

So Boras did what Boras always does: control the messaging. That doesn’t automatically mean the timeline is false. Skubal absolutely could return faster than expected. Medical advancements are real, and less invasive procedures can shorten recovery windows.

But Tigers fans are well within their right to be wary of reports that suddenly shifted from “we don’t know anything yet” to “this is practically a flu shot” once Boras entered the conversation publicly.

Mind you, the Tigers themselves have never spoken with that kind of certainty. Neither have independent medical experts. The loudest optimism has consistently come from Boras-aligned channels.

And after the emotional whiplash of this week, Tigers fans have every right to wait for Detroit’s doctors — not Scott Boras’ sales pitch — before believing Tarik Skubal will be back on a mound in early June.

Add us as a preferred source on Google

Follow